Literature DB >> 15693643

Clinically meaningful outcomes in patients with chronic obstructive pulmonary disease.

Richard L ZuWallack1, Margaret C Haggerty, Paul Jones.   

Abstract

Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation, gas exchange abnormalities, hyperinflation, and other pathophysiologic events. However, patients are usually unaware of these physical changes and only seek medical attention when distressing symptoms, such as dyspnea and exercise limitation, begin to appear. Therefore, it is reasonable to directly assess these clinical areas of importance to the patient, both as determinants of the impact of the disease process and as outcomes following intervention. Although many of the physiologic abnormalities of COPD are only partially or poorly reversible with treatment, dyspnea, exercise performance, and health status often show impressive gains with therapy. Incorporating clinically relevant outcome assessments complements traditional physiologic measurements and provides the clinician with a yardstick to determine whether a particular intervention is causing a meaningful improvement in the patient. This article discusses these clinical assessments and provides specific examples of their applicability and usefulness in treating patients with COPD.

Entities:  

Mesh:

Year:  2004        PMID: 15693643     DOI: 10.1016/j.amjmed.2004.10.020

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  Effect of hospital use of oral nutritional supplementation on length of stay, hospital cost, and 30-day readmissions among Medicare patients with COPD.

Authors:  Julia Thornton Snider; Anupam B Jena; Mark T Linthicum; Refaat A Hegazi; Jamie S Partridge; Chris LaVallee; Darius N Lakdawalla; Paul E Wischmeyer
Journal:  Chest       Date:  2015-06       Impact factor: 9.410

2.  Behavioral medicine approaches to chronic obstructive pulmonary disease.

Authors:  Andreas von Leupoldt; Anja Fritzsche; Ana F Trueba; Alicia E Meuret; Thomas Ritz
Journal:  Ann Behav Med       Date:  2012-08

3.  Factors associated with opioid dispensation for patients with COPD and lung cancer in the last year of life: A retrospective analysis.

Authors:  Donna Goodridge; Josh Lawson; Graeme Rocker; Darcy Marciniuk; Donna Rennie
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-05-06

4.  End-of-life care for persons with advanced chronic obstructive pulmonary disease: report of a national interdisciplinary consensus meeting.

Authors:  D M Goodridge; D D Marciniuk; D Brooks; A van Dam; S Hutchinson; P Bailey; S Baxter; P Dorasamy; S Dumont; S Hassan; P Hernandez; A Kerigan; G Rocker; D Wilson; J Young
Journal:  Can Respir J       Date:  2009 Sep-Oct       Impact factor: 2.409

5.  An Integral assessment framework of health status in chronic obstructive pulmonary disease (COPD).

Authors:  Jan H Vercoulen; Leonie Daudey; Johan Molema; Petra J Vos; Jeannette B Peters; Mariska Top; Hans Folgering
Journal:  Int J Behav Med       Date:  2008

6.  Airway inflammation contributes to health status in COPD: a cross-sectional study.

Authors:  Jiska B Snoeck-Stroband; Dirkje S Postma; Thérèse S Lapperre; Margot M E Gosman; Henk A Thiadens; Henk F Kauffman; Jacob K Sont; Désirée F Jansen; Peter J Sterk
Journal:  Respir Res       Date:  2006-11-30

Review 7.  Role of N-acetylcysteine in the management of COPD.

Authors:  Anna M Sadowska; J Verbraecken; K Darquennes; W A De Backer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

8.  Adequate Patient Characterization in COPD: Reasons to Go Beyond GOLD Classification.

Authors:  Tewe L Verhage; Yvonne F Heijdra; Johan Molema; Leonie Daudey; P N Richard Dekhuijzen; Jan H Vercoulen
Journal:  Open Respir Med J       Date:  2009-02-13

9.  Low income as a determinant of exercise capacity in COPD.

Authors:  Ana Sofia Porta; Nyanjok Lam; Paul Novotny; Roberto Benzo
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.